Cancer research depends on people volunteering to participate in clinical studies.
Written by Justin Harris; contact at 734-764-2220 or email@example.com.
Media contact: Nicole Fawcett, 734-764-2220 | Patients may contact Cancer AnswerLine™, 800-865-1125
A mutant protein found in nearly all pancreatic cancers plays a role not only in the cancer's development but in its continued growth, according to a new study from University of Michigan Rogel Cancer Center researchers.
Researchers at the University of Michigan, led by Max Wicha, M.D., have found that Avastin, Sutent increase breast cancer stem cells. This could explain the limited success of anti-angiogenesis treatments in breast cancer.
University of Michigan is first U.S. academic site to put GE's Veo, which greatly reduces the amount of radiation exposure and therefore, cancer risk, into clinical use.
Pavan Reddy, M.D., associate professor of hematology/oncology at the U-M Medical School, was the senior researcher who discovered alpha-1-antitrypsin -- a natural enzyme -- reduces intense inflammation after bone marrow transplant.
Researchers at the University of Michigan have found that matted lymph nodes appear to signal increased chance of oropharyngeal cancer spreading to other parts of the body.
In a new study, a program known as Spatially Invariant Vector Quantization (SIVQ) separated a malignancy from background tissue in digital slides of a type of bladder cancer whose features can vary widely and presents diagnostic challenges even for experts.
Cancer Center clinics and infusion will reopen Thursday, Jan. 12, as well as all phlebotomy and radiology services on Level B2.